Guangdong True Health Medical Technology Development Co., Ltd. (HKG:2697)

Hong Kong · Delayed Price · Currency is HKD

63.85

-1.80 (-2.74%)

Oct 15, 2026, 3:15 PM HKT

Market Cap	2.28B
Revenue (ttm)	20.41M +848.3%
Net Income	-108.29M
EPS	-3.37
Shares Out	35.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,539,020
Open	67.90
Previous Close	65.65
Day's Range	61.05 - 78.00
52-Week Range	62.00 - 886.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About HKG:2697

Guangdong True Health Medical Technology Development Co., Ltd. engages in in the research and development, manufacture and sale of surgical robots and disposables in the People’s Republic of China and Hong Kong. The company offers products, such as percutaneous puncture surgery robots, includes TH-S1, TH-S, TH-S Pro and TH-SA; microwave ablation surgical robot for the treatment of liver and lung tumors; percutaneous microwave ablation surgical robot TH-X HMW approved for the treatment of liver tumors; AI-based 3D reconstruction software for med... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2018

Employees 158

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2697

Full Company Profile

Financial Performance

In 2025, HKG:2697's revenue was 12.18 million, an increase of 579.96% compared to the previous year's 1.79 million. Losses were -90.11 million, -2.22% less than in 2024.

Financial numbers in CNY Financial Statements